Total: $577,000

Total: $1,176,000

For The 197 R&D Executives In BioWorld s Company Survey Who Received A Full Year Of Compensation (Base Salary Plus Bonus) Rank Executive Company Base Salary ($000) Bonus ($000) Total ($000) 1 Roger M. Perlmutter AMGEN INC 884 1,645 2,529 2 Richard H. Scheller GENENTECH INC 476 780 1,256 3 Norbert W. Bischofberger GILEAD SCIENCES INC 608 526 1,134 4 Phil D. Agrawal-Sudhir IDERA PHARMACEUTICALS 445 450 895 5 George D. Yancopoulos REGENERON PHARMA 544 335 879 6

Company Executive Base Salary ($000) Bonus ($000) Total ($000) Other ($000) Long-Term Comp. ($000) Total Direct Comp. ($000) Value Realizable On Exercise Of Options ($000) Value Realized On Vesting Of Restricted Stock ($000) AASTROM BIOSCIENCES INC Janet M. Hock 218 15 233 0 0 233 0 0 ACADIA PHARMACEUTICALS Roger Mills 335 31 365 0 62 262 0 0 ACCELRYS INC Mathew A. Hahn (1) 351 56 407 6 322 574 0 0 ACCESS PHARMACEUTICALS David P. Nowotnik 254 20 274 7

For The 104 Legal Officers In BioWorld s Company Survey Who Received A Full Year Of Compensation (Base Salary Plus Bonus) Rank Executive Company Base Salary ($000) Bonus($000) Total($000) 1 Stephen G. Juelsgaard GENENTECH INC 456 750 1,206 2 Peter Wirth GENZYME CORP 676 433 1,109 3 Peter J. O’Callaghan QLT INC 397 233 630 4 James H. Davis HUMAN GENOME SCI 376 245 621 5 W. Bradford Middlekauff MEDAREX INC 375 206 581 6 Laurie B. Keating MILLENNIUM PHARMA

Company Executive Base ($000) Bonus ($000) Total ($000) Other ($000) Long-Term Comp. ($000) Total Direct Comp. ($000) Value Realizable On Exercise Of Options ($000) Value Realized On Vesting Of Restricted Stock ($000) ACCENTIA BIOPHARMA Samuel S. Duffey 275 30 305 0 0 305 0 0 ACORDA THERAPEUTICS INC Jane Wasman 248 105 353 0 308 661 0 781 ADOLOR CORP Martha E. Manning 274 41 316 6 346 667 0 0 AFFYMETRIX INC Barbara Caulfield (1) 388 0 388 77 150

For The 94 COOs In BioWorld s Company Survey Who Received A Full Year Of Compensation (Base Salary Plus Bonus) Rank Executive Company Base Salary ($000) Bonus($000) Total($000) 1 Dennis M. Fenton AMGEN INC 849 1,295 2,144 2 Robert J. Hugin CELGENE CORP 607 1,470 2,077 3 John F. Milligan GILEAD SCIENCES INC 546 474 1,020 4 James W. O Shea SEPRACOR INC 525 236 761 5 Steven R. Arikian ACCENTIA BIOPHARMACEUTICALS 448 0 448 6 Elliot Goldstein MAXYGEN INC 438

Company Executive Base Salary ($000) Bonus ($000) Total ($000) Other $000) Long-Term Comp. Total Direct Comp. Value Realizable On Exercise Of Options ($000) Value Realized On Vesting Of Restricted Stock ($000) AASTROM BIOSCIENCES INC James A. Cour 273 35 308 17 0 325 0 0 ACCENTIA BIOPHARMA Steven R. Arikian 448 0 448 0 0 448 0 0 ACORDA THERAPEUTICS INC Mary Fisher 265 119 384 0 700 1,084 0 1,755 ACUSPHERE INC Michael R. Slater 241 47 288 3 36 327 0

Company Executive Base Salary ($000) Bonus ($000) Total ($000) Other ($000) Long-Term Comp. Total Direct Comp. Value Realizable On Exercise Of Options ($000) Value Realized On Vesting Of Restricted Stock ($000) AASTROM BIOSCIENCES Gerald D. Brennan Jr. 212 0 212 0 0 212 0 0 ACADIA PHARMA Thomas H. Aasen 271 49 320 12 163 495 27 0 ACCELRYS Rick E. Russo (1) 273 64 338 3 77 269 0 0 ACCENTIA BIOPHARMA Alan M. Pearce 250 0 250 0 0 250 0 0 ACCESS

For The 259 CFOs In BioWorld s Company Survey Who Received A Full Year Of Compensation (Base Salary Plus Bonus) Rank Executive Company Name Base Salary ($000) Bonus ($000) Total ($000) 1 Richard D. Nanula AMGEN INC 812 1,240 2,052 2 David A. Ebersman GENENTECH INC 440 870 1,310 3 John F. Milligan GILEAD SCIENCES INC 546 474 1,020 4 Michael S. Wyzga GENZYME CORP 468 433 901 5 J. Kevin Buchi CEPHALON INC 476 381 857 6 Peter N. Kellogg BIOGEN IDEC INC 568

For The 98 Business And Coporate Development Officers In BioWorld s Company Survey Who Received A Full Year Of Compensation (Base Salary Rank Executive Company Base Salary ($000) Bonus($000) Total($000) 1 Barry A. Labinger HUMAN GENOME SCIENCES INC 460 391 851 2 Victor Hartmann VERTEX PHARMACEUTICALS INC 450 355 804 3 Peter J. O Callaghan QLT INC 397 233 630 4 Robert McG. Lilley DIGENE CORP 359 268 627 5 Michael Cosgrave PHARMION CORP 399 174 573 6 Philip K

Executive Company Base Salary ($000) Bonus ($000) Total ($000) Other ($000) Long-Term Comp. ($000) Total Direct Comp. ($000) Value Realizable On Exercise Of Options ($000) Value Realized On Vesting Of Restricted Stock ($000) Brian Lundstrom ACADIA PHARMACEUTICALS INC 263 26 289 12 131 432 0 0 R. William Taylor ACCELRYS INC 240 99 339 1 144 484 0 0 Phillip S. Wise ACCESS PHARMACEUTICALS INC 200 25 225 0 41 183 0 0 Roger D. Graham Jr.(1) ADOLOR CORP 353

CEOs Whose Total Direct Compensation Exceeded $1 Million Executive Company Base Salary ($000) Bonus ($000) Other ($000) Long-Term Compensation ($000) Total Direct Compensation ($000) Kevin W. Sharer AMGEN INC 1,483 4,525 957 17,111 24,076 Henri A. Termeer GENZYME CORP 1,432 1,726 125 19,166 22,449 Arthur D. Levinson GENENTECH INC 995 2,725 444 12,960 17,124 Sol J. Barer CELGENE CORP 716 1,960 143 13,265 16,084 James C. Mullen BIOGEN IDEC INC 1,085

Rank Executive Company Bonus ($000) Base Salary ($000) Bonus As % Of Base Salary Other ($000) Stock Price 12/31/05 Stock Price 12/31/06 Percent Change In Stock Price 1 Kevin W. Sharer AMGEN 4,525 1,483 305.1 957 78.86 68.31 -13 2 Arthur D. Levinson GENENTECH 2,725 995 273.9 444 92.50 81.13 -12 3 Michael S. Weiss KERYX BIOPHARM 2,293 375 611.5 5 14.64 13.30 -9 4 James C. Mullen BIOGEN IDEC INC 2,000 1,085 184.3 123 45.28 49.19 9 5 Sol

Rank Executive Company Base Salary ($000) 2006 Base Salary ($000) 2005 Percent Change Base Salary Stock Price 12/31/05 Stock Price 12/31/06 Percent Change Stock Market Capitalization 12/31/06 ($M) 1 Kevin W. Sharer AMGEN INC 1,483 1,390 7 78.86 68.31 -13 61,332.5 2 Henri A. Termeer GENZYME CORP 1,432 1,365 5 70.78 61.58 -13 16,631.6 3 Frank Baldino Jr. CEPHALON INC 1,129 1,065 6 64.74 70.41 9 4,829.6 4 James C. Mullen BIOGEN IDEC INC 1

Company Executive Base Salary ($000) Bonus ($000) Total ($000) Other ($000) Long- Term Comp. ($000) Total Direct Comp. ($000) Base Salary Prior FY ($000) Percent Change In Base Salary Value Realizable On Exercise Of Options ($000) Value Realized On Vesting Of Restricted Stock ($000) Percentage Of Company Shares Owned by CEO Stock Price 12/31/05 Stock Price 12/31/06 Percent Change in Stock Shares Out (M) FYE Market Cap ($M) FY Revenues ($M) AASTROM BIOSCIENCES INC R. Douglas

For The 273 CEOs In BioWorld's Company Survey Who Received A Full Year Of Compensation (Base Salary Plus Bonus) Rank Executive Company Name Base Salary ($000) Bonus ($000) Total ($000) Stock Price 12/31/06 Shares Out (M) Approx. Mkt. Cap. 12/31/06 1 Kevin W. Sharer AMGEN INC 1,483 4,525 6,008 68.31 1,166.0 61,332.5 2 Arthur D. Levinson GENENTECH INC 995 2,725 3,720 81.13 1,053.0 83,179.0 3 Henri A. Termeer GENZYME CORP 1,432 1,726 3,157 61.58 263.0 16,631.6 4